Today's Top Stories | | By Leo Miller | February 3, 2025 09:36 AM |
| | | By The Associated Press | February 4, 2025 08:17 AM |
| | By Chris Markoch | February 4, 2025 08:57 AM |
| | | By The Associated Press | February 4, 2025 05:29 AM |
| | By Jea Yu | February 4, 2025 07:45 AM |
|
|
| This Phone Pays People For Using It (ad)While other cell phone carriers are always looking for ways to squeeze every last penny out of their customers, my company pays users for the 40 hours a week they are using smartphone apps, listening to music, and watching videos online with their phones.
And you can join us for just $0.26 per share. Plus, when you invest now, you can get up to 100% bonus shares! Let's change the future of mobile together. |
|
Your Watchlist | | | - Alphabet (NASDAQ:GOOGL) will be releasing earnings after the market closes on Tuesday, February 4, Financial Modeling Prep reports. (Register for Conference Call)
- CAO Amie Thuener O'toole sold 1,340 shares of the stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $202.08, for a total value of $270,787.20. Following the transaction, the chief accounting officer now owns 17,848 shares in the company, valued at approximately $3,606,723.84. This represents a 6.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
- (2/4) Alphabet Likely to Gain Big in Near Future Following Q4 Earnings Today (zacks.com)
- (2/4) China says to probe Google over anti-monopoly violations (techxplore.com)
- (2/4) China Immediately Retaliates Against Trump Tariffs. Coal, Gas and Google Are Targets. (barrons.com)
- (2/4) Alphabet Inc. (NASDAQ:GOOGL) CAO Sells $270,787.20 in Stock (marketbeat.com)
- (2/4) China reportedly hits back in Trump tariff wars targeting Google and others (proactiveinvestors.co.uk)
| - CEO Mark Zuckerberg sold 12,975 shares of the firm's stock in a transaction on Friday, January 31st. The stock was sold at an average price of $696.39, for a total value of $9,035,660.25. Following the transaction, the chief executive officer now owns 210,971 shares in the company, valued at approximately $146,918,094.69. This trade represents a 5.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
- (2/4) 1 No-Brainer Artificial Intelligence (AI) Stock That Will Crush the Market in 2025 (fool.com)
- (2/4) Mark Zuckerberg Says This Will Be a Huge AI Breakthrough in 2025 for Meta Platforms (fool.com)
- (2/4) China launches an antitrust probe into Google. Here's what it means (marketbeat.com)
- (2/4) When You Look Back on This Moment, You'll Wish You'd Bought This Trillion-Dollar Artificial Intelligence (AI) Stock (fool.com)
- (2/4) Meta Platforms, Inc. (NASDAQ:META) CEO Mark Zuckerberg Sells 12,975 Shares (marketbeat.com)
| |
| Manage Your Watchlist
|
Analysts' Upgrades | AMC Entertainment (NYSE:AMC) was upgraded by analysts at Roth Mkm from a "sell" rating to a "neutral" rating. They now have a $3.25 price target on the stock, down previously from $4.00. This represents a 3.0% upside from the current price of $3.16. | Aptiv (NYSE:APTV) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $77.00 price target on the stock, up previously from $63.00. This represents a 26.0% upside from the current price of $61.12. | Princeton Bancorp (NASDAQ:BPRN) was upgraded by analysts at Janney Montgomery Scott from a "neutral" rating to a "buy" rating. They now have a $35.00 price target on the stock. This represents a 10.6% upside from the current price of $31.65. | First Community (NASDAQ:FCCO) was upgraded by analysts at Janney Montgomery Scott from a "neutral" rating to a "buy" rating. They now have a $30.00 price target on the stock. This represents a 14.1% upside from the current price of $26.29. | Grab (NASDAQ:GRAB) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $5.45 price target on the stock, down previously from $5.50. This represents a 6.5% upside from the current price of $5.12. | Juniper Networks (NYSE:JNPR) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $40.00 price target on the stock. This represents a 14.2% upside from the current price of $35.02. | Mastercard (NYSE:MA) was upgraded by analysts at DZ Bank AG from a "hold" rating to a "buy" rating. They now have a $620.00 price target on the stock. This represents a 10.7% upside from the current price of $560.12. | Marriott International (NASDAQ:MAR) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $330.00 price target on the stock. This represents a 13.3% upside from the current price of $291.30. | Novartis (NYSE:NVS) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating.The current price is $105.44. | News (NASDAQ:NWSA) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.The current price is $28.58. | Palantir Technologies (NASDAQ:PLTR) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $95.00 price target on the stock, up previously from $60.00. This represents a 10.4% downside from the current price of $105.99. | Timken (NYSE:TKR) was upgraded by analysts at Bank of America Co. from an "underperform" rating to a "neutral" rating.The current price is $79.00. | Toyota Motor (NYSE:TM) was upgraded by analysts at Macquarie from a "neutral" rating to an "outperform" rating.The current price is $187.09. | Treace Medical Concepts (NASDAQ:TMCI) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $16.00 price target on the stock. This represents a 53.8% upside from the current price of $10.40. | Tyson Foods (NYSE:TSN) was upgraded by analysts at Piper Sandler from an "underweight" rating to a "neutral" rating. They now have a $58.00 price target on the stock. This represents a 2.3% upside from the current price of $56.72. |
| View More Upgrades
|
| Man behind OpenAI makes shocking new bet (ad)Billionaire Sam Altman has become one of the most powerful men in the world by running OpenAI…
But there's a far lesser known investment he's making that could put OpenAI to shame.
In fact this Sam Altman-backed company could actually become a crucial partner for OpenAI…
And the US Military… not to mention hundreds of other giant companies around the globe.
To make the story even crazier… this company only recently became viable, thanks to an obscure piece of legislation that President Trump signed before he left office…
Which ordered the government to take this incredible new technology seriously. Check out our report right here. |
|
Analysts' Downgrades | Autoliv (NYSE:ALV) was downgraded by analysts at HSBC Holdings plc from a "buy" rating to a "hold" rating. They now have a $100.00 price target on the stock, down previously from $109.00. This represents a 6.1% upside from the current price of $94.26. | Amphastar Pharmaceuticals (NASDAQ:AMPH) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $36.00 price target on the stock, down previously from $66.00. This represents a 8.4% upside from the current price of $33.21. | American Woodmark (NASDAQ:AMWD) was downgraded by analysts at Wolfe Research from an "outperform" rating to a "peer perform" rating.The current price is $75.78. | Brilliant Earth Group (NASDAQ:BRLT) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $1.60 price target on the stock, down previously from $4.00. This represents a 5.6% downside from the current price of $1.70. | B2Gold (NYSE:BTG) was downgraded by analysts at TD Securities from a "buy" rating to a "hold" rating.The current price is $2.45. | Calumet Specialty Products Partners (NASDAQ:CLMT) was downgraded by analysts at UBS Group AG from a "neutral" rating to a "sell" rating. They now have a $15.00 price target on the stock, down previously from $20.50. This represents a 12.3% downside from the current price of $17.11. | NIO (NYSE:NIO) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $4.70 price target on the stock. This represents a 5.5% upside from the current price of $4.46. | Napco Security Technologies (NASDAQ:NSSC) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating. They now have a $27.00 price target on the stock, down previously from $46.00. This represents a 2.6% upside from the current price of $26.31. | Napco Security Technologies (NASDAQ:NSSC) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating. They now have a $28.00 price target on the stock. This represents a 6.4% upside from the current price of $26.31. | Ollie's Bargain Outlet (NASDAQ:OLLI) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $111.00 price target on the stock, down previously from $125.00. This represents a 3.9% upside from the current price of $106.84. | Olin (NYSE:OLN) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating. They now have a $30.00 price target on the stock, down previously from $45.00. This represents a 7.3% upside from the current price of $27.96. | Reckitt Benckiser Group (OTCMKTS:RBGLY) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating.The current price is $13.19. |
| View More Downgrades
|
Analysts' New Coverage | AnaptysBio (NASDAQ:ANAB) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $25.00 price target on the stock. This represents a 43.6% upside from the current price of $17.41. | Celestica (NYSE:CLS) (TSE:CLS) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $140.00 price target on the stock. This represents a 11.2% upside from the current price of $125.93. | Catalyst Pharmaceuticals (NASDAQ:CPRX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $28.00 price target on the stock. This represents a 22.0% upside from the current price of $22.95. | Crinetics Pharmaceuticals (NASDAQ:CRNX) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $39.86. | Equinox Gold (NYSEAMERICAN:EQX) is now covered by analysts at TD Cowen. They set a "hold" rating and a $35.00 price target on the stock. This represents a 436.9% upside from the current price of $6.52. | 89bio (NASDAQ:ETNB) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.The current price is $9.70. | Chesapeake Energy (NASDAQ:EXE) is now covered by analysts at Raymond James. They set a "strong-buy" rating and a $135.00 price target on the stock. This represents a 29.4% upside from the current price of $104.36. | Oruka Therapeutics (NASDAQ:ORKA) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $20.00 price target on the stock. This represents a 40.2% upside from the current price of $14.27. | Orla Mining (NYSEAMERICAN:ORLA) is now covered by analysts at TD Cowen. They set a "hold" rating on the stock.The current price is $6.33. | Plexus (NASDAQ:PLXS) is now covered by analysts at Stifel Nicolaus. They set a "hold" rating and a $152.00 price target on the stock. This represents a 8.8% upside from the current price of $139.67. | Rambus (NASDAQ:RMBS) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $71.00 price target on the stock. This represents a 17.2% upside from the current price of $60.58. | Terreno Realty (NYSE:TRNO) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $71.00 price target on the stock. This represents a 8.3% upside from the current price of $65.56. | Vera Therapeutics (NASDAQ:VERA) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $49.00 price target on the stock. This represents a 32.7% upside from the current price of $36.91. | Venture Global (NYSE:VG) is now covered by analysts at Sanford C. Bernstein. They set a "market perform" rating and a $20.00 price target on the stock. This represents a 3.7% downside from the current price of $20.76. | ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $19.00 price target on the stock. This represents a 156.4% upside from the current price of $7.41. |
| View More New Coverage
|
Calendars from MarketBeat | |
|
Get 30 Days of MarketBeat All Access Free | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| Start Your 30-Day Free Trial |
| Upgrade Your Subscription | Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | Upgrade Now |
|
| Manage Your Watchlist | View and add up to five holdings to your watchlist. | View My Portfolio |
|
| Join Our Facebook Group | Join MarketBeat's free stock discussion and trading idea group on Facebook. | Join Now |
|
|
No comments:
Post a Comment